Sundaram Multi Pap Limited Board Approves Q3 FY26 Unaudited Standalone Financial Results
Sundaram Multi Pap Limited's board of directors convened on February 14, 2026, and approved unaudited standalone financial results for Q3 FY26 and nine months ended December 31, 2025. The three-hour meeting was held at the company's Mumbai facility under Chairman & Managing Director Amrut P Shah's leadership, ensuring compliance with SEBI Regulation 33 requirements and providing stakeholders with updated financial performance data.

*this image is generated using AI for illustrative purposes only.
Sundaram Multi Pap Limited has announced the successful completion of its board meeting held on February 14, 2026, where key financial results were approved for the third quarter of fiscal year 2026. The meeting took place at the company's premises located at 5/6 Papa Industrial Estate, Suren Road, Andheri (East), Mumbai, spanning three hours from 11:00 AM to 2:00 PM.
Board Meeting Details and Venue
The board meeting was conducted under the leadership of Chairman & Managing Director Amrut P Shah, who holds DIN 00033120. The meeting was held in compliance with regulatory requirements and followed the intimation submitted to stock exchanges on February 6, 2026.
| Meeting Parameter: | Details |
|---|---|
| Date: | February 14, 2026 |
| Commencement Time: | 11:00 AM |
| Conclusion Time: | 2:00 PM |
| Venue: | 5/6 Papa Industrial Estate, Suren Road, Andheri (East), Mumbai 400093 |
| Presiding Officer: | Amrut P Shah, Chairman & Managing Director |
Financial Results Approval
The primary agenda of the board meeting focused on the consideration and approval of unaudited standalone financial results. The directors approved the financial performance data for both the quarter and nine months ended December 31, 2025, marking the completion of Q3 FY26 reporting requirements.
The financial results were prepared in accordance with applicable accounting standards and were accompanied by a Limited Review Report issued by the company's auditors. This approval ensures compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Compliance and Documentation
The company has fulfilled its regulatory obligations by formally communicating the board meeting outcome to both BSE Limited and National Stock Exchange of India Limited. The communication was digitally signed by Chairman & Managing Director Amrut P Shah on February 14, 2026, at 14:09:27 +05'30', ensuring proper documentation and timestamp verification.
| Exchange Details: | Information |
|---|---|
| BSE Scrip Code: | 533166 |
| NSE Symbol: | SUNDARAM |
| Regulation Reference: | SEBI Regulation 33 |
| Reporting Period: | Quarter and nine months ended December 31, 2025 |
The approval of these unaudited standalone financial results represents a significant milestone in the company's quarterly reporting cycle, providing stakeholders with updated financial information for the third quarter and nine-month period of fiscal year 2026.
Historical Stock Returns for Sundaram Multi Pap
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.20% | +1.82% | -4.00% | -16.42% | -17.65% | +15.86% |































